Kazuki Hayashi
- Rheumatology top 1%
- IgG4-Related and Inflammatory Diseases 33
- Surgery top 2%
- Gastrointestinal disorders and treatments 38
- Pediatric Hepatobiliary Diseases and Treatments 33
- Esophageal and GI Pathology 32
- Pancreatitis Pathology and Treatment 31
-
- Gallbladder and Bile Duct Disorders 53
- Hepatology top 5%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 46
-
- Neuroendocrine Tumor Research Advances 19
- Co-authors
- Takashi JohTakahiro NakazawaItaru NaitohHirotaka OharaKatsuyuki MiyabeFumihiro OkumuraMichihiro YoshidaTomoaki Ando
- Journals
- SHILAP Revista de lepidopterología (4 papers)PLoS ONE (3 papers)Scientific Reports (3 papers)
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Kazuki Hayashi
154 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 86
- Rheumatology 812
- Surgery 1.8k
- Pulmonary and Respiratory Medicine 976
- Hepatology 167
- Oncology 533
Countries citing papers authored by Kazuki Hayashi
This map shows the geographic impact of Kazuki Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Hayashi more than expected).
Fields of papers citing papers by Kazuki Hayashi
This network shows the impact of papers produced by Kazuki Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Hayashi. The network helps show where Kazuki Hayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazuki Hayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 14 | |
| 17 | 2019 | 11 | |
| 18 | 2018 | 5 | |
| 19 | 2018 | 6 | |
| 20 | 2017 | 18 |
About Kazuki Hayashi
Kazuki Hayashi is a scholar working on Surgery, Medical Laboratory Technology and Rheumatology, having authored 163 papers that have together received 2.3k indexed citations. Recurring topics across this work include Gallbladder and Bile Duct Disorders (53 papers), Pancreatic and Hepatic Oncology Research (46 papers), Gastrointestinal disorders and treatments (38 papers), IgG4-Related and Inflammatory Diseases (33 papers), Pediatric Hepatobiliary Diseases and Treatments (33 papers), Esophageal and GI Pathology (32 papers), Pancreatitis Pathology and Treatment (31 papers) and Neuroendocrine Tumor Research Advances (19 papers). The work is most often cited by research in Rheumatology (812 citations), Surgery (1.8k citations) and Pulmonary and Respiratory Medicine (976 citations). Kazuki Hayashi has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Takashi Joh, Takahiro Nakazawa, Itaru Naitoh, Hirotaka Ohara, Katsuyuki Miyabe, Fumihiro Okumura, Michihiro Yoshida, Tomoaki Ando, Hitoshi Sano and Hiroaki Yamashita. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.